Nir Sassi - 04 Aug 2021 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role: Chief Financial Officer
Issuer symbol: INDP
Report date: 04 Aug 2021
Net transaction value: $0
Form type: 4
Accepted by SEC: 06 Aug 2021, 17:00:57 UTC
Previous filing: 02 Aug 2021
Next filing: 28 Feb 2022
SEC filing: View on sec.gov
Reporting owner signature: /s/ Nir Sassi

Key filing fact

Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 06 Aug 2021.

Key facts

This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Aug 2021, 17:00.

Change

Previous filing in this sequence was filed on 02 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INDP transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +35,000
Change %
Price: $0.000000
Shares after: 35,000
Date: 04 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $8.87
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests and becomes exercisable over a period of twelve months in four equal quarterly installments and accelerate upon termination of Mr. Sassi's consulting agreement with Indaptus Therapeutics, Inc.